AVANDIA

Prescription medicines

AVANDIA

Product information:

AVANDIA product monograph

Patient Informed Consent Package:

AVANDIA Patient Informed Consent Form

AVANDIA Consumer Information

Health Care Professional Information:

November 9, 2010 - Health Canada Endorsed Information on Important New Restrictions on the use of rosiglitazone (AVANDIA, AVANDAMET and AVANDARYL)

November 1, 2007 - Health Canada endorsed important safety information regarding AVANDIA, AVANDAMET and AVANDARYL

June 1, 2007 - Health Canada endorsed important safety information regarding AVANDIA and AVANDAMET

February 23, 2007 - Health Canada endorsed important safety information regarding AVANDIA and AVANDAMET

December 19, 2005 - Health Canada endorsed important safety information regarding AVANDIA and AVANDAMET

November 13, 2001 - Important safety information regarding AVANDIA (rosiglitazone maleate)

Public Communications:

November 18, 2010 - Health Canada Endorsed Information on Important New Restrictions on the use of rosiglitazone (AVANDIA, AVANDAMET and AVANDARYL)

November 6, 2007 - Health Canada endorsed important safety information regarding AVANDIA, AVANDAMET and AVANDARYL

May 30, 2007 - Health Canada endorsed important safety information on AVANDIA and AVANDAMET

February 28, 2007 - Health Canada endorsed important safety information on AVANDIA and AVANDAMET

December 20, 2005 - Health Canada endorsed important safety information on AVANDIA and AVANDAMET

 

Trademarks are owned by or licensed to the GSK group of companies.